{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-21-333913","form_type":"8-K","ticker":"BIO","cik":"0000012208","company_name":"BIO-RAD LABORATORIES, INC.","filed_at":"2021-11-18T23:59:59+00:00","discovered_at":"2026-05-14T18:04:11.829289+00:00","generated_at":"2026-06-28T06:51:43.958923+00:00","sec_items":["1.01","2.03","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Bio-Rad amends credit agreement to add LIBOR fallback, expand EBITDA definition, increase debt/asset sale baskets","bullets":["Adds LIBOR replacement language to credit agreement; updates benchmark provisions.","Expands EBITDA to include non-recurring cash expenses (transaction costs, milestone payments, restructuring).","Provides unlimited cash and cash equivalent basket measured against leverage ratio, net of cash up to $200M globally.","Increases baskets for indebtedness, asset sales, cross-defaults, and judgment liens."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-21-333913","json":"https://secwatch.observer/filing/0001193125-21-333913.json","markdown":"https://secwatch.observer/filing/0001193125-21-333913.md","text":"https://secwatch.observer/filing/0001193125-21-333913.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/12208/000119312521333913/0001193125-21-333913-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/12208/000119312521333913/d437115d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T06:51:43.958923+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}